fixed-dose combination therapy

Glenmark Pharma gets approval from Health Canada for nasal spray Ryaltris

Glenmark Pharmaceuticals on Friday announced approval by Health Canada for its nasal spray Ryaltris used in symptomatic treatment of moderate to severe seasonal allergic rhinitis